Towards determining appropriate hydrodynamic conditions for in vitro in vivo correlations using computational fluid dynamics

European Journal of Pharmaceutical Sciences

Volumn 37, Issue 3-4, 2009, Pages 291-299

  D'Arcy, Deirdre M ^a   Healy, Anne Marie ^a   Corrigan, Owen I ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

CFD; Dissolution; Hydrodynamics; IVIVC

Indexed keywords

ACETYLSALICYLIC ACID; HYDROFLUMETHIAZIDE;

ARTICLE; COMPUTATIONAL FLUID DYNAMICS; DRUG ABSORPTION; DRUG DOSAGE FORM; DRUG RELEASE; DRUG SOLUBILITY; FLOW RATE; GASTROINTESTINAL MOTILITY; HYDRODYNAMICS; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL;

ABSORPTION; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BODY FLUIDS; CHEMISTRY, PHARMACEUTICAL; COMPUTER SIMULATION; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; KINETICS; REPRODUCIBILITY OF RESULTS; SOLUBILITY; WATER;

EID: 67349107479     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.02.016     Document Type: Article

References (45)

1. Abrahamsson B., Pal A., Sjöberg M., Carlsson M., Laurell E., and Brasseur J.G. A novel in vitro and numerical analysis of shear-induced drug release from extended-release tablets in the fed stomach. Pharm. Res. 22 (2005) 1215-1226
2. Abrahamsson B., Roos K., and Sjögren J. Investigation of prandial effects on hydrophilic matrix tablets. Drug Dev. Ind. Pharm. 25 (1999) 765-771
3. Arnold J.H. Studies in diffusion. II. A kinetic theory of diffusion in liquid systems. J. Am. Chem. Soc. 52 (1930) 3937-3955
4. Bai G., and Armenante P.M. Hydrodynamic, mass transfer, and dissolution effects induced by tablet location during dissolution testing. J. Pharm. Sci. (2008) 10.1002/jps.21512
5. Bai G., Armenante P.M., and Plank R.V. Experimental and computational determination of blend time in USP dissolution testing apparatus II. J. Pharm. Sci. 96 (2007) 3072-3086
6. Bradshaw L.A., Irimia A., Sims J.A., Gallucci M.R., Palmers R.L., and Richards W.O. Biomagnetic characterization of spatiotemporal parameters of the gastric slow wave. Neurogastroenterol. Motil. 18 (2006) 619-631
7. Corrigan O.I., and Timoney R.F. Anomalous behaviour of some hydroflumethiazide crystal samples. J. Pharm. Pharmacol. 26 (1974) 838-840
8. Corrigan O.I., and Timoney R.F. Towards standardizing agitation conditions in the beaker dissolution method. Int. J. Pharm. 1 (1978) 299-302
9. CPMP, 1999. Note for Guidance on Quality of Modified Release Products: A: Oral Dosage Forms, B: Transdermal Dosage Forms. Section 1 (Quality). European Agency for the Evaluation of Medicinal Products, London, UK.
10. D'Arcy D.M., Corrigan O.I., and Healy A.M. Hydrodynamic simulation (computational fluid dynamics) of asymmetrically positioned tablets in the paddle dissolution apparatus: impact on dissolution rate and variability. J. Pharm. Pharmacol. 57 (2005) 1243-1250
11. D'Arcy D.M., Corrigan O.I., and Healy A.M. Evaluation of hydrodynamics in the basket dissolution apparatus using computational fluid dynamics-dissolution rate implications. Eur. J. Pharm. Sci. 27 (2006) 259-267
12. Diebold S.M. Physiological parameters relevant to dissolution testing: hydrodynamic considerations. In: Dressman J., and Krämer J. (Eds). Pharmaceutical Dissolution Testing (2005), Taylor and Francis Group, Boca Raton
13. Dokoumetzidis A., and Macheras P. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. Int. J. Pharm. 321 (2006) 1-11
14. Dressman J.B., and Reppas C. In vitro in vivo correlations for lipophilic, poorly soluble drugs. Eur. J. Pharm. Sci. 11 (2000) S73-S80
15. Edwards L.J. The dissolution and diffusion of aspirin in aqueous media. Trans. Faraday Soc. 47 (1951) 1191-1210
16. Emami J. In vitro in vivo correlation: from theory to applications. J. Pharm. Pharmaceut. Sci. 9 (2006) 169-189
17. ®, 2003. Gambit Modelling Guide. Gambit (R) Documentation 2.1. Fluent (Ansys) Inc., Lebanon, NH, USA.
18. Gregory D.P., and Riddiford A.C. Transport to the surface of a rotating disk. J. Chem. Soc. (1956) 3756-3764
19. Jantratid E., Janssen N., Reppas C., and Dressman J.B. Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update. Pharm. Res. 25 (2008) 1663-1676
20. Katori N., Aoyagi N., and Terao T. Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation. Pharm. Res. 12 (1995) 237-243
21. Lerk C.F., and Lagas M. Studies on the USP-NF rotating basket and the beaker dissolution apparatus. II. Intrinsic dissolution rates. Pharm. Weekbl. 112 (1977) 925-931
22. Levich V.G. Physicochemical Hydrodynamics (1962), Prentice Hall Inc., Englewood Cliffs, NJ, USA
23. Levy G., and Hayes B.A. Physicochemical basis of the buffered acetylsalicylic acid controversy. N. Engl. J. Med. 262 (1960) 1053-1058
24. Levy G., and Hollister L.E. Inter- and intra-subject variations in drug absorption kinetics. J. Pharm. Sci. 53 (1964) 1446-1452
25. Levy G., Leonards J.R., and Procknal J.A. Development of in vitro dissolution tests which correlate quantitatively with dissolution rate-limited drug absorption in man. J. Pharm. Sci. 54 (1965) 1719-1722
26. Li S., He H., Parthiban L.J., Yin H., and Serajuddin A.T.M. IVIVC considerations in the development of immediate-release oral dosage form. J. Pharm. Sci. 94 (2005) 1396-1417
27. McCarthy L.G., Bradley G., Sexton J.C., Corrigan O.I., and Healy A.M. Computational fluid dynamics modeling of the paddle dissolution apparatus: agitation rate, mixing patterns and fluid velocities. AAPSPharmSciTech 5 (2004) (Article 31).
28. McCarthy L.G., Kosiol C., Healy A.M., Bradley G., Sexton J.C., and Corrigan O.I. Simulating the hydrodynamic conditions in the United States Pharmacopoeia paddle dissolution apparatus. AAPSPharmSciTech 4 (2003) (Article 22)
29. Needs C.J., and Brooks P.M. Clinical pharmacokinetics of the salicylates. Clin. Pharmacokinet. 10 (1985) 164-177
30. Neuvonen P.J., and Kivisto K.T. Enhancement of drug absorption by antacids-an unrecognized drug interaction. Clin. Pharmacokinet. 27 (1994) 120-128
31. Nogami H., Nagai T., and Suzuki A. Studies on powdered preparations. 17. Dissolution rate of sulfonamides by rotating disk method. Chem. Pharm. Bull. 14 (1966) 329-338
32. Pal A., Indireshkumar K., Schwizer W., Abrahamsson B., Fried M., and Brasseur J.G. Gastric flow and mixing studied using computer simulation. Proc. R. Soc. Lond. B: Biol. Sci. 271 (2004) 2587-2594
33. Parojcic J., and Corrigan O.I. Rationale for ibuprofen co-administration with antacids: potential interaction mechanisms affecting drug absorption. Eur. J. Pharm. Biopharm. 69 (2008) 640-647
34. Radovanovic J., Duric Z., Jovanovic M., Ibric S., and Petrovic M. An attempt to establish an in vitro-in vivo correlation: case of paracetamol immediate-release tablets. Eur. J. Drug Metab. Pharmacokinet. 23 (1998) 33-40
35. Rossi R.C., Dias C.L., Donato E.M., Martins L.A., Bergold A.M., and Fröehlich P.E. Development and validation of dissolution test for ritonavir soft gelatin capsules based on in vivo data. Int. J. Pharm. 338 (2007) 119-124
36. Rostami-Hodjegan A., Shiran M.R., Tucker G.T., Conway B.R., Irwin W.J., Shaw L.R., and Grattan T.J. A new rapidly absorbed paracetamol tablet containing sodium bicarbonate. II. Dissolution studies and in vitro/in vivo correlation. Drug Dev. Ind. Pharm. 28 (2002) 533-543
37. Schiller C., Fröhlich C.-P., Giessmann T., Siegmund W., Mönnikes H., Hosten N., and Weitschies W. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment. Pharmacol. Ther. 22 (2005) 971-979
38. Schulze K. Imaging and modelling of digestion in the stomach and the duodenum. Neurogastroenterol. Motil. 18 (2006) 172-183
39. Stevens L.E., and Missel P.J. Impact of density gradients on flow-through dissolution in a cylindrical flow cell. Pharm. Dev. Technol. 11 (2006) 529-534
40. Sunesen V.H., Pedersen B.L., Kristensen H.G., and Müllertz A. In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media. Eur. J. Pharm. Sci. 24 (2005) 305-313
41. USP. United States Pharmacopeia 31/National Formulary 26 (2008), The United States Pharmaceutical Convention Inc., Rockwell, MD, USA
42. In: Visawanth D.S., and Natarajan G. (Eds). Databook on the Viscosity of Liquids (1989), Hemisphere Publishing Corporation, USA
43. Withey R.J. The kinetics of dissolution for a non-disintegrating standard substrate. J. Pharm. Pharmacol. 23 (1971) 573-582
44. Withey R.J., and Bowker A.J. Agitation of the solvent in tablet dissolution studies-a flow visualisation technique. J. Pharm. Pharmacol. 24 (1972) 345-351
45. Yong C.S., Oh Y.-K., Lee K.H., Park S.-M., Park Y.-J., Gil Y.S., Yu C.H., Yoo B.-K., Woo J.S., Kim J.O., Rhee J.-D., Kim C.-K., and Choi H.-G. Trials of clear aceclofenac-loaded soft capsules with accelerated oral absorption in humans. Int. J. Pharm. 302 (2005) 78-83